Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 9,320 shares at $6.62 ($59K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Open-market sale of $59k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.62 | 200 | $1K | 2.2% |
| 2 | $6.37 | 9,120 | $58K | 97.8% |
| Total | $6.38 avg | 9,320 | $59K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-11 | $129K | — | Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |